Release Date: 28/10/13 08:43 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 9.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%